IMPURITIES AVAILABLE FOR 'Lapaquistat'

Omsynth Lifesciences Pvt. Ltd. is one of the leading manufacturer and exporter of Lapaquistat. Lapaquistat is a cholesterol-lowering agent that acts as a squalene synthase inhibitor, targeting a key enzyme in the cholesterol biosynthesis pathway downstream of HMG-CoA reductase. By blocking squalene formation, it reduces hepatic cholesterol synthesis without significantly affecting nonsterol isoprenoid production, potentially minimizing side effects seen with statins. Lapaquistat effectively lowers LDL cholesterol and total cholesterol levels in the blood. It was developed as an oral therapeutic agent for the treatment of hypercholesterolemia and atherosclerosis. Although clinical trials showed promising lipid-lowering effects, its development was discontinued due to concerns about liver toxicity at higher doses. Despite this, lapaquistat remains of pharmacological interest for its novel mechanism in modulating cholesterol metabolism and cardiovascular risk. Buy high quality Lapaquistat from Omsynth Lifesciences.